The estimated Net Worth of Paul C Redmond is at least $1.3 million dollars as of 13 May 2013. Paul Redmond owns over 5,000 units of Edwards Lifesciences Corp stock worth over $855,446 and over the last 16 years Paul sold EW stock worth over $439,679.
Paul has made over 6 trades of the Edwards Lifesciences Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently Paul sold 5,000 units of EW stock worth $336,750 on 13 May 2013.
The largest trade Paul's ever made was exercising 43,600 units of Edwards Lifesciences Corp stock on 12 May 2011 worth over $1,530,796. On average, Paul trades about 5,058 units every 37 days since 2009. As of 13 May 2013 Paul still owns at least 12,534 units of Edwards Lifesciences Corp stock.
You can see the complete history of Paul Redmond stock trades at the bottom of the page.
Paul's mailing address filed with the SEC is ONE EDWARDS WAY, , IRVINE, CA, 92614.
Over the last 22 years, insiders at Edwards Lifesciences Corp have traded over $94,964,396 worth of Edwards Lifesciences Corp stock and bought 47,398 units worth $3,992,090 . The most active insiders traders include Michael A Mussallem, Donald E Jr Bobo et Steven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of $1,126,057. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth $226,400.
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: